A Day Up For MiNK Therapeutics Inc.

Mon, Aug 15, 2022 at 07:00 PM

MiNK Therapeutics Inc. (INKT:NASDAQ) rocketted at $3.4, a gain of 98.8%. On Mon, Aug 15, 2022, INKT:NASDAQ hit a New 2-Week High of $3.4. The stock appeared on our News Catalysts scanner on Tue, Aug 09, 2022 at 10:47 AM in the 'INVESTOR UPDATE' category. From Mon, Aug 01, 2022, the stock recorded 70.00% Up Days and 63.64% Green Days

About MiNK Therapeutics Inc. (INKT:NASDAQ)

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other life-threatening...

Top 10 Gainers:

Magic Empire Global Limited (MEGL:NASDAQ), 115.69%
MiNK Therapeutics Inc. (INKT:NASDAQ), 98.83%
Regis Corporation (RGS:NYSE), 75.15%
Team, Inc. (TISI:NYSE), 57.79%
Viridian Therapeutics Inc. (VRDN:NASDAQ), 49.36%
Terns Pharmaceuticals Inc. (TERN:NASDAQ), 45.7%
GigaMedia Limited (GIGM:NASDAQ), 41.46%
Revlon, Inc. (REV:NYSE), 30.64%
Qualtek Services Inc Cl A (QTEK:NASDAQ), 28.82%
RCM Technologies, Inc. (RCMT:NASDAQ), 26.82%